arrow
C

Christina Y. Weng

Cullen Eye Institute
H指数:24
被引数:2,052

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 2-year efficacy and safety results from the GATHER2 phase 3 trial

阿瓦辛卡帕德·贝戈尔(Avacincaptad pegol)用于年龄相关性黄斑变性继发的地理性萎缩:GATHER2三期试验2年的疗效和安全性结果

2025-12-150
OAAI
Characterization of Visual Field Loss Over 4 Years in the Rate of Progression in USH2A-Related Retinal Degeneration (RUSH2A) Study

USH2A相关视网膜变性的视野损失进展率特征:4年随访研究(RUSH2A研究)

2025-05-220
PRE
Visual Acuity, Full-field Stimulus Thresholds, and Electroretinography for 4 Years in The Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) Study
2025-03-010
OAAI
Characterizing the Genetic Basis for Inherited Retinal Disease: Lessons Learned From the Foundation Fighting Blindness Clinical Consortium's Gene Poll
2025-02-062
OAAI
International Classification System for Ocular Complications of Anti-VEGF Agents in Clinical Trials
2024-12-010
OA
Self-Reported Functional Vision in USH2A-Associated Retinal Degeneration as Measured by the Michigan Retinal Degeneration Questionnaire
2024-06-043
OAAI